GleamWall
中文EN

PRGO PERRIGO Co plc

Pharmaceutical Preparations · NYSE · SEC CIK 1585364 · Fiscal year ends 12/31

Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.5%
TTM net income YoY-3,316.4%
TTM EPS YoY-3,351.4%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—

Margins

Gross margin32.3%
Operating margin-39.4%
Net margin-43.3%
FCF margin4.1%
EBITDA margin-33.6%

Returns

ROE-51.4%
ROA-20.1%
ROIC (approx.)-19.7%
Asset turnover0.47x

Leverage & solvency

Liabilities / assets67.4%
Debt / equity1.35x
Current ratio2.35x
Interest coverage—

Cash quality & payout

Operating cash flow / net income-0.14x
Accruals ratio-22.9%
Payout ratio—
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$4.25B$4.37B
Cost of revenue$2.76B$2.83B
Gross profit$1.49B$1.54B
R&D expense$95.40M$112.20M
SG&A expense$435.90M$468.00M
Operating income-$1.12B$112.90M
Pretax income-$1.30B-$80.70M
Income tax$104.40M$80.00M
Net income-$1.43B-$171.80M
EBITDA-$784.70M$438.80M
EPS (basic)-10.29-1.25
EPS (diluted)-10.29-1.25
Dividends declared per share1.161.10
Weighted avg. shares (diluted)138.50M137.40M
Balance sheet
Cash & equivalents$531.60M$558.80M
Receivables$612.80M$642.30M
Inventory$1.15B$1.08B
Current assets$2.80B$2.48B
PP&E, net$898.70M$917.80M
Goodwill$2.05B$3.32B
Intangibles$4.76B$4.50B
Total assets$8.54B$9.65B
Current liabilities$1.01B$1.04B
Short-term debt$36.60M$36.40M
Long-term debt$3.60B$3.58B
Total debt$3.64B$3.62B
Total liabilities$5.60B$5.33B
Shareholders' equity$2.94B$4.32B
Net debt$3.11B$3.06B
Shares outstanding137.60M136.50M
Cash flow statement
Operating cash flow$238.50M$362.90M
Capital expenditure$93.40M$118.30M
Free cash flow$145.10M$244.60M
Investing cash flow-$75.40M$78.80M
Financing cash flow-$220.50M-$611.00M
Depreciation & amortization$337.50M$325.90M
Stock-based compensation$54.60M$64.40M
Dividends paid$159.30M$152.50M

Free plan shows the latest 2 periods; Pro shows all 14 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.